Xinxin Ren
发表
Xi Chen,
Xue Yang,
Jie Wei,
2019,
PeerJ.
Xi Chen,
Zhi Li,
Jie Wei,
2019,
PloS one.
SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling
Yi-di Guan,
Lu Zhang,
Rong Tan,
2022,
Oncogene.
Z. Qiu,
Yi-di Guan,
Lunquan Sun,
2021,
Cancer Research.
Xi Chen,
Xue Yang,
Jian-hua Zhou,
2019,
Molecular medicine reports.
Kunlun Huang,
Xiaoyun He,
Yue Li,
2022,
Frontiers in Pharmacology.
Xi Chen,
Jie Wei,
Zhijie Xu,
2020,
Molecular medicine reports.
Xi Chen,
Xue Yang,
Jie Wei,
2018,
Front. Oncol..
Xi Chen,
Zhijie Xu,
Yuanliang Yan,
2022,
Clinical and translational medicine.
Zhijie Xu,
Yuanliang Yan,
Shuangshuang Zeng,
2021,
Acta pharmaceutica Sinica. B.
Xi Chen,
Jinwu Peng,
Zhijie Xu,
2022,
Frontiers in Pharmacology.
Zhijie Xu,
Yuanliang Yan,
Shuangshuang Zeng,
2020,
Frontiers in Cell and Developmental Biology.
Xi Chen,
Zhijie Xu,
Yuanliang Yan,
2021,
Frontiers in Bioengineering and Biotechnology.
Xi Chen,
Jinwu Peng,
Zhijie Xu,
2022,
Aging.
Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
Zhijie Xu,
Yuanliang Yan,
Xiang Wang,
2021,
International journal of general medicine.
Yi-di Guan,
Tao Chen,
Xiuping Zhang,
2022,
International journal of biological sciences.
Xi Chen,
Jinwu Peng,
Zhijie Xu,
2021,
Genes & diseases.
Lu Zhang,
Liang Weng,
Yumei Duan,
2022,
Oncogene.